Impact of empagliflozin on diabetic kidney disease

被引：1
|
作者：
Koya, Daisuke [1 ,2 ]
机构：
[1] Dept Diabetol Endocrinol Div Anticipatory Mol Foo, Kanazawa Medical Univers, Ishikawa, Japan
[2] Kanazawa Med Univ, Dept Diabetol & Endocrinol, Div Anticipatory Mol Food Sci & Technol, Uchinada, Ishikawa, Japan
来源：
JOURNAL OF DIABETES INVESTIGATION | 2017年 / 8卷 / 05期
关键词：
D O I：
10.1111/jdi.12615
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：658 / 660
页数：3
相关论文
共 50 条
  • [21] Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
    Motrapu, Manga
    Swiderska, Monika Katarzyna
    Mesas, Irene
    Marschner, Julian Aurelio
    Lei, Yutian
    Martinez Valenzuela, Laura
    Fu, Jia
    Lee, Kyung
    Angelotti, Maria Lucia
    Antonelli, Giulia
    Romagnani, Paola
    Anders, Hans-Joachim
    Anguiano, Lidia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (08): : 1729 - 1745
  • [22] Effects of Empagliflozin on Urinary Megalin and Its Ligand a1-Microglobulin in Patients with Diabetic Kidney Disease
    Hosojima, Michihiro
    Kabasawa, Hideyuki
    Saito, Akihiko
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [23] EFFECTS OF EMPAGLIFLOZIN ON KIDNEY AND CARDIACMRI MEASURES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Judge, Parminder
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I48 - I49
  • [24] The impact of multimorbidity on the effects of empagliflozin in chronic kidney disease (CKD): exploratory analyses from the EMPA-KIDNEY trial
    Mayne, Kaitlin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I112 - I114
  • [25] The impact of multimorbidity on the effects of empagliflozin in chronic kidney disease (CKD): exploratory analyses from the EMPA-KIDNEY trial
    Mayne, Kaitlin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [26] Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from theEMPA-REG OUTCOMEtrial
    Wanner, Christoph
    Inzucchi, Silvio E.
    Zinman, Bernard
    Koitka-Weber, Audrey
    Mattheus, Michaela
    George, Jyothis T.
    von Eynatten, Maximilian
    Hauske, Sibylle J.
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2335 - 2347
  • [27] IMPACT OF DIABETIC KIDNEY DISEASE ON CORONARY ARTERY PLAQUE PROGRESSION
    Yabushita, Sayaka
    Kishi, Satoru
    Tanaka, Tetsu
    Aihara, Hideaki
    Ogura, Yoshiyasu
    Tsukada, Hiroyuki
    Furuse, Satoshi
    Mise, Naobumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I461 - I462
  • [28] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Wanner, Christoph
    Inzucchi, Silvio E.
    Lachin, John M.
    Fitchett, David
    von Eynatten, Maximilian
    Mattheus, Michaela
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 323 - 334
  • [29] Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway
    Lu, QianYu
    Yang, LiJiao
    Xiao, Jing-Jie
    Liu, Qing
    Ni, LiHua
    Hu, Jun-Wei
    Yu, Hong
    Wu, XiaoYan
    Zhang, Bai -Fang
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 195 : 89 - 102
  • [30] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Pareek, Anil
    Chandurkar, Nitin
    Naidu, Kumar
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18): : 1800 - 1800
12345